ENTRY       D08620                      Drug
NAME        Toremifene (INN);
            Fareston (TN)
FORMULA     C26H28ClNO
EXACT_MASS  405.1859
MOL_WEIGHT  405.9596
CLASS       Antineoplastic
             DG01585  Estrogen receptor antagonist
              DG01620  Tamoxifene-type antineoplastic
            Hormonal agent
             DG01619  Estrogen receptor antagonist/modulator
            Metabolizing enzyme substrate
             DG01633  CYP3A/CYP3A4 substrate
              DG02913  CYP3A4 substrate
REMARK      Same as: C08166
            ATC code: L02BA02
            Chemical structure group: DG00735
            Product (DG00735): D00967<JP/US>
EFFICACY    Antineoplastic, Estrogen receptor antagonist
TARGET      NR3A (ESR) [HSA:2099 2100] [KO:K08550 K08551]
            IGF1R (CD221) [HSA:3480] [KO:K05087]
  PATHWAY   hsa04014(3480)  Ras signaling pathway
            hsa04915(2099+2100)  Estrogen signaling pathway
            hsa05205(2099+3480)  Proteoglycans in cancer
METABOLISM  Enzyme: CYP3A4 [HSA:1576]
INTERACTION  
STR_MAP     map07043  Antineoplastics - hormones
            map07226  Progesterone, androgen and estrogen receptor agonists/antagonists
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
              L02 ENDOCRINE THERAPY
               L02B HORMONE ANTAGONISTS AND RELATED AGENTS
                L02BA Anti-estrogens
                 L02BA02 Toremifene
                  D08620  Toremifene (INN)
            Drug groups [BR:br08330]
             Antineoplastic
              DG01585  Estrogen receptor antagonist
               DG01620  Tamoxifene-type antineoplastic
                DG00735  Toremifene
                 D08620  Toremifene
             Hormonal agent
              DG01619  Estrogen receptor antagonist/modulator
               DG00735  Toremifene
                D08620  Toremifene
             Metabolizing enzyme substrate
              DG01633  CYP3A/CYP3A4 substrate
               DG02913  CYP3A4 substrate
                DG00735  Toremifene
                 D08620  Toremifene
            Target-based classification of drugs [BR:br08310]
             Nuclear receptors
              Estrogen like receptors
               Estrogen receptor
                NR3A (ESR)
                 D08620  Toremifene (INN)
             Protein kinases
              Receptor tyrosine kinases (RTK)
               INSR family
                IGF1R (CD221)
                 D08620  Toremifene (INN)
            Drug metabolizing enzymes and transporters [br08309.html]
             Drug metabolizing enzymes
              D08620
            Drug groups [BR:br08330]
             Antineoplastic
              DG01585  Estrogen receptor antagonist
               DG01620  Tamoxifene-type antineoplastic
                DG00735  Toremifene
             Hormonal agent
              DG01619  Estrogen receptor antagonist/modulator
               DG00735  Toremifene
             Metabolizing enzyme substrate
              DG01633  CYP3A/CYP3A4 substrate
               DG02913  CYP3A4 substrate
                DG00735  Toremifene
DBLINKS     CAS: 89778-26-7
            PubChem: 96025304
            ChEBI: 9635
            PDB-CCD: T0R
            LigandBox: D08620
            NIKKAJI: J33.157K
ATOM        29
            1   C8x C    17.5000  -19.3200
            2   C8x C    17.5000  -20.7200
            3   C8x C    18.6900  -21.4200
            4   C8x C    19.9500  -20.7200
            5   C8y C    19.9500  -19.3200
            6   C8x C    18.6900  -18.6200
            7   C8x C    22.4000  -20.7200
            8   C8y C    22.4000  -19.3200
            9   C2c C    21.1400  -18.6200
            10  C8x C    23.5900  -21.4200
            11  C8y C    24.7800  -20.7200
            12  C8x C    24.7800  -19.3200
            13  C8x C    23.5900  -18.6200
            14  C2c C    21.1400  -17.2200
            15  C8y C    22.4000  -16.5200
            16  C1b C    19.9500  -16.5200
            17  C1b C    18.7600  -17.2200
            18  X   Cl   17.5700  -16.5200
            19  C8x C    23.5900  -17.2200
            20  C8x C    24.7800  -16.5200
            21  C8x C    24.7800  -15.1200
            22  C8x C    23.5900  -14.4200
            23  C8x C    22.4000  -15.1200
            24  O2a O    26.0400  -21.4200
            25  C1b C    27.2300  -20.7200
            26  C1b C    28.4200  -21.4200
            27  N1c N    29.6100  -20.7200
            28  C1a C    30.8000  -21.4200
            29  C1a C    29.6100  -19.3200
BOND        31
            1     1   2 2
            2     2   3 1
            3     3   4 2
            4     4   5 1
            5     5   6 2
            6     1   6 1
            7     7   8 1
            8     8   9 1
            9     5   9 1
            10    7  10 2
            11   10  11 1
            12   11  12 2
            13   12  13 1
            14    8  13 2
            15    9  14 2
            16   14  15 1
            17   14  16 1
            18   16  17 1
            19   17  18 1
            20   15  19 2
            21   19  20 1
            22   20  21 2
            23   21  22 1
            24   22  23 2
            25   15  23 1
            26   11  24 1
            27   24  25 1
            28   25  26 1
            29   26  27 1
            30   27  28 1
            31   27  29 1
///
